Vnitr Lek 2021, 67(8):E37-E38 | DOI: 10.36290/vnl.2021.133

24hodinová mortalita seniorů akutně hospitalizovaných pro interní onemocnění - může být ovlivněna přítomností diabetu jako komorbidity?

Jan Brož1, Martina Nováková2, Milan Kvapil2
1 Interní klinika 2. LF UK a FN Motol, Praha
2 Geriatrická interní klinika 2. LF UK a FN Motol, Praha

Published: December 9, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Brož J, Nováková M, Kvapil M. 24hodinová mortalita seniorů akutně hospitalizovaných pro interní onemocnění - může být ovlivněna přítomností diabetu jako komorbidity? Vnitr Lek. 2021;67(8):E37-38. doi: 10.36290/vnl.2021.133.
Download citation

References

  1. Dúbrava M, Kiňová S, Jánošiová J. 24-hodinová mortalita seniorov akútne hospitalizovaných pre internistické ochorenie. Vnitr Lek. 2021; 67(6): E03-E07 Go to original source...
  2. International Diabetes Federation IDF diabetes altas, 9th edn Brussels: IDF, 2019. [online] [cit. 24. 10. 2021] Dostupné z: https://www.diabetesatlas.org/en/
  3. Kvapil M. Počet diabetiků v České republice. VVV 2019; Supplementum, S34.
  4. Diabetes‑Related Inpatient Stays, 2018, [online] [cit. 23. 10. 2021] Dostupné z: https://www.hcup‑us.ahrq.gov/reports/statbriefs/sb279-Diabetes‑Inpatient‑Stays-2018.jsp
  5. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in‑hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002 Mar; 87(3): 978-982. Go to original source...
  6. Gore MO, Patel MJ, Kosiborod M, Parsons LS, Khera A, de Lemos JA, Rogers WJ, Peterson ED, Canto JC, McGuire DK; National Registry of Myocardial Infarction Investigators. Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarction. Circ Cardiovasc Qual Outcomes. 2012 Nov; 5(6): 791-797. Go to original source... Go to PubMed...
  7. Smerdely P. Mortality is not increased with Diabetes in hospitalised very old adults: a multi‑site review. BMC Geriatr. 2020 Dec 3; 20(1): 522. Go to original source... Go to PubMed...
  8. Brož J, Janíčková Žďárská D, Urbanová J et al. Current Level of Glycemic Control and Clinical Inertia in Subjects Using Insulin for the Treatment of Type 1 and Type 2 Diabetes in the Czech Republic and the Slovak Republic: Results of a Multinational, Multicenter, Observational Survey (DIAINFORM). Diabetes Ther. 2018 Oct; 9(5): 1897-1906. Go to original source...
  9. Brož J, Janíčková Žďárská D, Urbanová J et al. Jak dobře léčíme inzulinem v České republice a ve Slovenské republice Shrnutí výsledků a komentář originální česko‑slovenské studie DIAINFORM. Vnitr Lek. 2019; 65(4): 279-283. Go to original source... Go to PubMed...
  10. Brož J, Janíčková Žďárská D, Urbanová J et al. Insulin Management of Patients with Inadequately Controlled Type 2 Diabetes Admitted to Hospital: Titration Patterns and Frequency of Hypoglycemia as Results of a Prospective Observational Study (Hospital Study). Diabetes Ther. 2021 Jul; 12(7): 1799-1808. Go to original source...
  11. Brož J, Honěk P, Dušek L, Pavlík T, Kvapil M. Mortalita pacientů s diabetes mellitus léčených perorálními antidiabetiky v České republice poklesla během let 2003-2013 a přiblížila se populačnímu průměru. Vnitr Lek 2015, 61(Suppl 3): 14-20.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.